| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |